PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsHidroxicloroquina
Hidroxicloroquina
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
598 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369—C80146———19
Pancreatic neoplasmsD010190EFO_0003860C25812———18
MelanomaD008545——85——212
Breast neoplasmsD001943EFO_0003869C5079———12
AdenocarcinomaD000230——77——111
Lung neoplasmsD008175—C34.9049———10
Colorectal neoplasmsD015179——27———9
Prostatic neoplasmsD011471—C6156———9
Non-small-cell lung carcinomaD002289——46———7
CarcinomaD002277—C80.065———7
Show 101 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Multiple myelomaD009101—C90.04————4
Plasma cell neoplasmsD054219——4————4
Immunosuppression therapyD007165——1———12
Rheumatic diseasesD012216—M79.01———12
Digestive system neoplasmsD004067——2————2
FibrosisD005355——2————2
Pancreatic ductal carcinomaD021441——1———12
PlasmacytomaD010954—C90.31————1
Respiratory aspirationD053120EFO_1001839—1————1
Myeloid leukemia acuteD015470—C92.01————1
Show 12 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Macular degenerationD008268EFO_0001365H35.30————33
Retinal diseasesD012164—H35.9————33
Critical illnessD016638——————22
DiarrheaD003967—R19.7————22
Psoriatic arthritisD015535EFO_0003778L40.5————22
Chronic urticariaD000080223—L50.8————22
UrticariaD014581EFO_0005531L50————22
Systemic sclerodermaD012595EFO_0000717M34————11
Localized sclerodermaD012594EFO_1001361L94.0————11
Diffuse sclerodermaD045743EFO_0000404—————11
Show 36 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
386 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use